Reply: De novo mutations in CLDN5: alternating hemiplegia of childhood or not?
Brain
.
2023 Aug 1;146(8):e59-e60.
doi: 10.1093/brain/awad054.
Authors
Isabelle Desguerre
1
,
Melodie Aubart
1
,
Yosuke Hashimoto
2
,
Karine Poirier
3
,
Anna Kaminska
1
,
Marianne Alison
4
,
Nathalie Boddaert
1
3
5
,
Arnold Munnich
1
3
,
Matthew Campbell
2
Affiliations
1
Departments of Pediatric Neurology and Medical Genetics, Hospital Necker-Enfants Malades, Université Paris Cité, Paris F-75015, France.
2
Smurfit Institute of Genetics, Trinity College Dublin, Dublin 2, Ireland.
3
INSERM UMR1163, Institut Imagine, Paris University, Paris 75015, France.
4
Department of Pediatric Radiology, Hospital Robert Debré, Université Paris Cité, Paris F-75015, France.
5
Department of Pediatric Radiology, Hospital Necker Enfants Malades, Université Paris Cité, Paris F-75015, France.
PMID:
36825462
PMCID:
PMC10393392
DOI:
10.1093/brain/awad054
No abstract available
Publication types
Editorial
Comment
MeSH terms
Claudin-5 / genetics
Hemiplegia* / genetics
Humans
Mutation / genetics
Substances
CLDN5 protein, human
Claudin-5
Supplementary concepts
Alternating hemiplegia of childhood